Hospital
Saint Joseph Regional Medical Center- Plymouth Campus INC
Saint Joseph Regional Medical Center- Plymouth Campus INC was paid $6.48M by Medicaid between Jan 2018 and Nov 2024, across 99 billing codes. Its largest line is 99283, emergency room visit (moderate) — 31% of everything it billed.
33Billing provider infoSAINT JOSEPH REGIONAL MEDICAL CENTER- PLYMOUTH CAMPUS INC
PLYMOUTH, IN 46563
PLYMOUTH, IN 46563
33aNPI1174571129assigned 05/04/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$6.48M
24GClaims132,089
24DCodes billed99
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Indiana
Rank by total paid#41 of 69
Median peer was paid$9.76M
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official KARAM, CHRISTOPHER controls 11+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,150 | $479K | |
| 2019 | 13,090 | $359K | |
| 2020 | 14,933 | $529K | |
| 2021 | 17,213 | $755K | |
| 2022 | 31,343 | $1.46M | |
| 2023 | 21,443 | $1.50M | |
| 2024incomplete | 17,917 | $1.39M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 31% | 13,706 | 12,065 | $2.00M |
| 41899 | Unlisted procedure, dentoalveolar structures | 15% | 487 | 442 | $958K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 14% | 5,719 | 4,960 | $926K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6.6% | 3,390 | 3,052 | $431K |
| 71045 | Radiologic examination, chest; single view | 5.5% | 2,474 | 2,087 | $353K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.7% | 2,248 | 1,774 | $305K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 4.3% | 5,288 | 4,004 | $279K |
| 71046 | Radiologic examination, chest; 2 views | 3.0% | 1,419 | 1,220 | $193K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.6% | 2,597 | 1,846 | $169K |
| 80053 | Comprehensive metabolic panel | 1.3% | 15,015 | 11,992 | $83K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.1% | 664 | 613 | $74K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.1% | 19,526 | 14,993 | $73K |
87 more codes
| 41115 | <1% | 98 | $52K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 360 | $50K |
| 36415 | Collection of venous blood by venipuncture | <1% | 25,776 | $50K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 620 | $44K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 531 | $31K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 234 | $26K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,851 | $26K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,645 | $25K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 76 | $25K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 16 | $24K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 178 | $23K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 582 | $22K |
| 80061 | Lipid panel | <1% | 2,195 | $17K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 463 | $17K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 718 | $15K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 31 | $14K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 281 | $13K |
| 81001 | <1% | 7,365 | $13K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 120 | $13K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 465 | $12K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 474 | $11K |
| 87631 | <1% | 58 | $10K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 314 | $10K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 689 | $9K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 928 | $7K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,453 | $7K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 30 | $6K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 661 | $5K |
| 85027 | <1% | 928 | $5K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 38 | $4K |
| 84703 | <1% | 804 | $4K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 165 | $4K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 144 | $4K |
| 74018 | <1% | 28 | $3K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 31 | $3K |
| 80081 | <1% | 44 | $2K | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 1,275 | $2K |
| 83655 | <1% | 191 | $2K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 131 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 661 | $2K |
| G0378 | Hospital observation service, per hour | <1% | 218 | $2K |
| 84484 | <1% | 233 | $2K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 30 | $1K |
| 83605 | <1% | 220 | $1K | |
| 83690 | <1% | 416 | $1K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 16 | $1K |
| 86762 | <1% | 107 | $1K | |
| 86780 | <1% | 120 | $1K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 13 | $1K |
| 87634 | <1% | 33 | $1K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 86 | $975.13 |
| 81025 | <1% | 278 | $970.77 | |
| 87660 | <1% | 52 | $757.97 | |
| 87480 | <1% | 52 | $737.92 | |
| 87510 | <1% | 52 | $737.92 | |
| 87340 | <1% | 106 | $675.43 | |
| 86803 | <1% | 53 | $621.44 | |
| 86850 | <1% | 159 | $562.79 | |
| 82043 | <1% | 118 | $547.99 | |
| 82728 | <1% | 74 | $501.77 | |
| 82570 | <1% | 106 | $450.60 | |
| 83735 | <1% | 88 | $415.41 | |
| 73630 | <1% | 12 | $380.70 | |
| 83550 | <1% | 76 | $335.44 | |
| 84439 | <1% | 68 | $330.14 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 12 | $306.81 |
| 88143 | <1% | 19 | $291.24 | |
| 83540 | <1% | 75 | $264.05 | |
| 86900 | <1% | 119 | $256.59 | |
| 86901 | <1% | 119 | $256.58 | |
| 82077 | <1% | 12 | $184.25 | |
| 82607 | <1% | 14 | $180.17 | |
| 85730 | <1% | 24 | $118.98 | |
| 85610 | <1% | 24 | $84.96 | |
| 82950 | <1% | 12 | $55.11 | |
| 85014 | <1% | 12 | $39.24 | |
| J2704 | Injection, propofol, 10 mg | 0% | 432 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 373 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 380 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 87 | $0.00 |
| 83880 | 0% | 24 | $0.00 | |
| G0471 | Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) | 0% | 81 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 385 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 95 | $0.00 |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 0% | 351 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 431 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 0% | 37 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKARAM, CHRISTOPHER (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Saint Joseph Regional Medical Center-South Bend Campus, INC. | Mishawaka, IN | $18.69M |
| Saint Joseph Regional Medical Center, INC. | Mishawaka, IN | $10.66M |
| Saint Joseph Regional Medical Center, INC. | Plymouth, IN | $5.55M |
| Saint Joseph Regional Medical Center-South Bend Campus, INC. | Mishawaka, IN | $4.81M |
| Saint Joseph Regional Medical Center-South Bend Campus, INC. | South Bend, IN | $923K |
| Saint Joseph Regional Medical Center- Plymouth Campus INC | Plymouth, IN | $771K |
| Saint Joseph Regional Medical Center-South Bend Campus, INC | Mishawaka, IN | $374K |
| Saint Joseph Regional Medical Center-South Bend Campus, INC. | Mishawaka, IN | $10K |
| Saint Joseph Regional Medical Center- Plymouth Campus INC | Plymouth, IN | $9K |
| Orthocare Pain and Rehabilitation Medicine LLC | Maple Shade, NJ | $1K |
| Saint Joseph Regional Medical Center-South Bend Campus, INC. | South Bend, IN | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.